JPRN-jRCT2072230062
Recruiting
未知
Investigator-initiated clinical trial to investigate the safety and efficacy of intravenous vagal nerve stimulation catheter for bradycardia in patients with supraventricular tachyarrhythmia
Sakamoto Kazuo0 sites20 target enrollmentSeptember 12, 2023
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Atrial fibrillation/Atrial flutter/Atrial tachycardia etc.
- Sponsor
- Sakamoto Kazuo
- Enrollment
- 20
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Patients aged 18 years or older at the time of obtaining consent
- •2\) Patients with supraventricular tachyarrhythmia who undergo catheter ablation
- •3\) Patients who have been fully informed, understood and given free written consent by the investigator or sub\-investigator of the study
- •4\) Patients with no cardiac dysfunction (left ventricular ejection fraction more than 50%) at level 1\-1
Exclusion Criteria
- •1\) Patients with anomaly of the superior vena cava
- •2\) Patients with uncontrolled gastric and duodenal ulcers
- •3\) Patients with implanted pacemaker (including leadless pacemaker), ICD (including S\-ICD) and CRT
- •4\) Patients with a temporary pacemaker inserted
- •5\) Patients with contraindications to contrast media or severe allergy to contrast media
- •6\) Patients with any kind of metal allergy
- •7\) Patients with active bleeding
- •8\) Patients with NYHA class IV
- •9\) Patients with severe haemodynamic compromise, such as cardiogenic shock
- •10\) Patients who are pregnant or potentially pregnant, or who wish to become pregnant during participation in the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Investigator-initiated clinical research trial on the effects of 5% Minoxidil topical foam on gene expression, hair growth and scalp microenvironment in men with androgenetic alopeciaAndrogenetic Alopecia Hamilton-Norwood IIIv-IV male patientsMedDRA version: 16.1Level: PTClassification code 10068168Term: Androgenetic alopeciaSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]EUCTR2013-004130-15-DECharité-Universitätsmedizin Berlin, Department of Dermatology, Clinical Research Center for Hair and Skin Science12
Recruiting
Phase 2
AllinOne-K-2JPRN-jRCT1080224639Takuya Takahashi10
Active, not recruiting
Phase 1
Investigator-initiated Clinical Trial to Evaluate the Safety and Efficacy of AX-1911, Magnetic Field Generator for Magnetic Targeting, in Knee OsteoarthritisKnee OsteoarthritisJPRN-jRCT2062210039Kamei Naosuke5
Recruiting
Phase 3
Omegaven investigator-initiated trialJPRN-jRCT2021230032Wada Motoshi20
Active, not recruiting
Phase 1
Investigator-initiated Clinical Trial to Evaluate the Safety and Efficacy of Magnetic targeting using Autologous Bone Marrow-derived Mesenchymal Stem Cell (m-MSC) in Knee OsteoarthritisKnee OsteoarthritisJPRN-jRCT2063210037Kamei Naosuke5